Sign in
4

Changes in Ownership

Boundless Bio, Inc. Filed Acc 0000950170-24-099299

Options or other derivatives

  • Chief Medical Officer acquired 316,895 shares (grant or award)
  • Chief Medical Officer returned 316,895 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Wagner Klaus W. Chief Medical Officer 2024-08-19 Returned to the company · Stock Option −102,564 0 D
Wagner Klaus W. Chief Medical Officer 2024-08-19 Returned to the company · Stock Option −9,635 0 D
Wagner Klaus W. Chief Medical Officer 2024-08-19 Returned to the company · Stock Option −94,871 0 D
Wagner Klaus W. Chief Medical Officer 2024-08-19 Returned to the company · Stock Option −68,080 0 D
Wagner Klaus W. Chief Medical Officer 2024-08-19 Returned to the company · Stock Option −41,745 0 D
Wagner Klaus W. Chief Medical Officer 2024-08-19 Grant or award · Stock Option +102,564 102,564 D
Wagner Klaus W. Chief Medical Officer 2024-08-19 Grant or award · Stock Option +9,635 9,635 D
Wagner Klaus W. Chief Medical Officer 2024-08-19 Grant or award · Stock Option +94,871 94,871 D
Wagner Klaus W. Chief Medical Officer 2024-08-19 Grant or award · Stock Option +68,080 68,080 D
Wagner Klaus W. Chief Medical Officer 2024-08-19 Grant or award · Stock Option +41,745 41,745 D
Loading xslF345X05/ownership.xml…